Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. 1998

T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
Department of Rheumatology, Leiden University Medical Center, The Netherlands.

We compared the state of activation and proliferation of T cells in synovial tissue (ST) from rheumatoid arthritis (RA) patients in early and late stages of the disease to find out whether T-cell-driven immune responses vary during the course of the disease. ST was obtained from 12 patients with early RA (< 1 year) and 12 patients with longstanding RA (> 5 years). T cells and interferon-gamma (IFN-gamma)-positive cells were detected in ST using immunohistologic methods. To determine the percentage of T cells expressing the interleukin-2 receptor, IFN-gamma, or the proliferation associated antigen Ki-67, immunofluorescence double-staining techniques were used. The scores for the number of T cells and for the expression of IFN-gamma as well as the percentages of T cells expressing CD25, IFN-gamma, or Ki-67 in rheumatoid synovium were not dependent on disease duration. These results do not support the assumption that the responsiveness of T cells in ST of RA patients differs between early and late stages of the disease. The data indicate that at present no arguments exist that the effect of T-cell-directed interventions on synovial inflammation might vary in different stages of the disease.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
January 1977, Scandinavian journal of rheumatology,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
November 2006, Clinical rheumatology,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
January 1995, Pathobiology : journal of immunopathology, molecular and cellular biology,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
January 2024, Clinical rheumatology,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
November 1998, Annals of the rheumatic diseases,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
December 1995, Clinical immunology and immunopathology,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
August 1984, The Journal of rheumatology,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
January 1988, Scandinavian journal of rheumatology. Supplement,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
April 1990, Arthritis and rheumatism,
T J Smeets, and Dolhain RJEM, and A M Miltenburg, and R de Kuiper, and F C Breedveld, and P P Tak
October 2007, Arthritis and rheumatism,
Copied contents to your clipboard!